<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Vestnik dermatologii i venerologii</journal-id><journal-title-group><journal-title xml:lang="en">Vestnik dermatologii i venerologii</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник дерматологии и венерологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0042-4609</issn><issn publication-format="electronic">2313-6294</issn><publisher><publisher-name xml:lang="en">Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1279</article-id><article-id pub-id-type="doi">10.25208/vdv1279</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОР ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Post-acne symptom complex. Approaches to therapy</article-title><trans-title-group xml:lang="ru"><trans-title>Симптомокомплекс постакне. Подходы к терапии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7689-8350</contrib-id><contrib-id contrib-id-type="spin">6938-4768</contrib-id><name-alternatives><name xml:lang="en"><surname>Drozhdina</surname><given-names>Marianna B.</given-names></name><name xml:lang="ru"><surname>Дрождина</surname><given-names>Марианна Борисовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Assistant professor, PhD, MD, Professor of the department od dermatovenereology and cosmetology</p></bio><bio xml:lang="ru"><p>доцент, кандидат медицинских наук, доцент кафедры дерматовенерологии и косметологии</p></bio><email>drozhdina@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2306-1423</contrib-id><contrib-id contrib-id-type="spin">2534-4480</contrib-id><name-alternatives><name xml:lang="en"><surname>Bobro</surname><given-names>Varvara A.</given-names></name><name xml:lang="ru"><surname>Бобро</surname><given-names>Варвара Андреевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>postgraduate student</p></bio><bio xml:lang="ru"><p>аспирант кафедры дерматовенерологии и косметологии</p></bio><email>bobro.va@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5484-778X</contrib-id><name-alternatives><name xml:lang="en"><surname>Sennikova</surname><given-names>Yuliana A.</given-names></name><name xml:lang="ru"><surname>Сенникова</surname><given-names>Юлиана Алексеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>student</p></bio><bio xml:lang="ru"><p>студент 6 курса лечебного факультета</p></bio><email>sennikova.yuliana@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kornilova</surname><given-names>Evgeniya I.</given-names></name><name xml:lang="ru"><surname>Корнилова</surname><given-names>Евгения Игоревна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>dermatologist</p></bio><bio xml:lang="ru"><p>врач-дерматолог</p></bio><email>doctorbeauty@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Kirov State Medical Academy</institution></aff><aff><institution xml:lang="ru">Кировский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Kirov Regional Clinical Skin-Venereologic Dispensary</institution></aff><aff><institution xml:lang="ru">Кировский областной клинический кожно-венерологический диспансер</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-05-25" publication-format="electronic"><day>25</day><month>05</month><year>2022</year></pub-date><volume>98</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>28</fpage><lpage>41</lpage><history><date date-type="received" iso-8601-date="2021-09-20"><day>20</day><month>09</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-04-19"><day>19</day><month>04</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Drozhdina M.B., Bobro V.A., Sennikova Y.A., Kornilova E.I.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Дрождина М.Б., Бобро В.А., Сенникова Ю.А., Корнилова Е.И.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Drozhdina M.B., Bobro V.A., Sennikova Y.A., Kornilova E.I.</copyright-holder><copyright-holder xml:lang="ru">Дрождина М.Б., Бобро В.А., Сенникова Ю.А., Корнилова Е.И.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikdv.ru/jour/article/view/1279">https://vestnikdv.ru/jour/article/view/1279</self-uri><abstract xml:lang="en"><p>Postacne-persistent skin changes that appear as a result of long-term acne, inadequate therapy and manipulations performed in the management of this group of patients. The post-acne symptom complex is stable skin changes that appear as a result of long-term acne inadequate therapy and manipulations performed during the management of this group of patients. The pathogenetic mechanisms underlying the launch of acne currently look as follows: androgens cause hyperseborrhea, sebum lipids activate innate immunity; pathological keratinization due to the production of IL-1 inflammatory mediator and androgen hyperproduction; <italic>Cutibacterium acnes</italic> activate innate immune responses through toll-like receptors and metalloproteinases, stimulate the production of antimicrobial peptides and sebum production. The subsequent rupture of the follicles activates the wound healing process. Depending on the genetically determined features of the course of the inflammatory process, various individual postacne changes of the skin will prevail in different patients. The article highlights the main factors influencing the formation of post-acne, pathogenetic mechanisms underlying the formation of these changes, systematizes modern data on the classification, morphological and pathohistological characteristics of scars. Quantitative and qualitative scales of assessment of post-acne scars for determining the severity of the pathological process are presented, differentiated approaches to modern methods of therapy are discussed in detail, including the advantages and disadvantages of the most common methods of treating patients based on the principles of evidence-based medicine using a number of personalized methods.</p></abstract><trans-abstract xml:lang="ru"><p>Симптомокомплекс постакне — устойчивые изменения кожи, появляющиеся в результате длительно существующих акне, а также при неадекватной терапии и проведенных манипуляций в процессе ведения данной группы пациентов. Патогенетические механизмы, лежащие в основе запуска акне, в настоящее время выглядят следующим образом: андрогены вызывают гиперсеборею, липиды кожного сала активируют врожденный иммунитет; формируется патологическая кератинизация вследствие выработки медиатора воспаления IL-1, гиперпродукции андрогенов и простагландинов; <italic>Cutibacterium acnes</italic> активируют реакции врожденного иммунитета через толл-подобные рецепторы и металлопротеиназы, стимулируют выработку антимикробных пептидов и продукцию кожного сала. Последующий разрыв фолликулов активирует процесс заживления ран. В зависимости от генетически детерминированных особенностей течения воспалительного процесса у разных пациентов будут превалировать те или иные индивидуальные постакне-изменения. В статье выделены основные факторы, оказывающие влияние на формирование постакне, патогенетические механизмы, лежащие в основе формирования этих изменений, систематизированы современные данные о классификации, морфологической и патогистологической характеристиках рубцов. Представлены количественная и качественная шкалы оценки рубцов постакне для определения степени тяжести патологического процесса, подробно обсуждены дифференцированные подходы к современным методам терапии, включая преимущества и недостатки наиболее распространенных методик лечения пациентов на основе принципов доказательной медицины с использованием ряда персонифицированных методик.</p></trans-abstract><kwd-group xml:lang="en"><kwd>postacne</kwd><kwd>postinflamation hyperpigmentation</kwd><kwd>post-acne scars</kwd><kwd>systemic isotretinoin</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>постакне</kwd><kwd>поствоспалительная гиперпигментация</kwd><kwd>рубцы постакне</kwd><kwd>системный изотретиноин</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Hazel H Oon, Su-Ni Wong, Derrick Chen Wee Aw, WaiKwong Cheong, Chee Leok Goh, HiokHee Tan. Acne Management Guidelines by the Dermatological Society of Singapore. J Clin Aesthet Dermatol. 2019;12(7):34–50.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clinical and Experimental Dermatology. 1994;19(4):303–308. doi: 10.1111/j.1365-2230.1994.tb01200.x</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Layton AM. Optimal management of acne to prevent scarring and psychological sequelae. Am J Clin Dermotol.2001;2:135–141. doi: 10.2165/00128071-200102030-00002</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Isedeh P, Kohli I, Al-Jamal M, Agbai ON, Chaffins M, Devpura S, et al. An in vivo model for postinflammatory hyperpigmentation: an analysis of histological, spectroscopic, colorimetric and clinical traits. Br J Dermatol. 2016;174(4):862–868.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Wolfram D, Tzankov A, Pülzl P, Piza-Katzer H. Hypertrophic scars and keloids—a review of their pathophysiology, risk factors, and therapeutic management. Dermatologic Surgery. 2009;35(2):171–181. doi: 10.1111/j.1524-4725.2008.34406.x</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends in Cell Biology. 2005;15(11):599–607. doi: 10.1016/j.tcb.2005.09.002</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Holland DB, Jeremy AHT, Roberts SG, Seukeran DC, Layton AM, Cunliffe WJ. Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar. British Journal of Dermatology. 2004;150(1):72–81. doi: 10.1111/j.1365-2133.2004.05749.x</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Stadelmann WK, Digenis AG, Tobin GR. Physiology and healing dynamics of chronic cutaneous wounds. American Journal of Surgery. 1998;176(2A):26S–38S. doi: 10.1016/s0002-9610(98)00183-4</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatologic Surgery. 2005;31(6):674–686. doi: 10.1111/j.1524-4725.2005.31612</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Chivot M, Pawin H, Beylot C, Chosidow O, Dreno B, Faure M. Acne scars: epidemiology, physiopathology, clinical features and treatment. Annales de Dermatologieet de Venereologie. 2006;133(10):813–824. doi: 10.1016/s0151-9638(06)71053-5</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Рябова В.В., Кошкин С.В., Зайцева Г.А., Евсеева А.Л. Характер распределения антигенов HLA I класса у пациентов со среднетяжелыми и тяжелыми формами акне. Иммунопатология, аллергология, инфектология. 2017;3:75–78. [Ryabova VV, Koshkin SV, Zaitseva GA, Evseeva AL. Character of distribution of immunological indicators in patients with average and severe forms of acne. Immunopathology, allergology, infectology.2017;3:75–78 (In Russ.)]. doi: 10.14427/jipai.2017.3.75</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Deirdre Connolly, Ha Linh Vu, Kavita Mariwalla, Nazanin Saedi. Acne Scarring-Pathogenesis, Evaluation, and Treatment Options. J Clin Aesthet Dermatol. 2017;10(9):12–23.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Дрождина М.Б. Фульминантные акне. Современное решение проблемы. Вестник дерматологии и венерологии. 2019;95(4):79–86. [Drozhdina MB. Fulminant acne. Modern solution to the problem. Bulletin of Dermatology and Venereology. 2019;95(4):79–86 (In Russ.)]. doi: 10.25208/0042-4609-2019-95-4-79-86</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Дрождина М.Б., Колеватых Е.П., Трубникова М.А., Кряжева П.А. Возрастные корреляции вульгарных акне. Сравнительное исследование микробиома и экспосома акне у студентов Кировского ГМУ. Анализ результатов терапии применительно к показателям качества жизни. Вестник дерматологии и венерологии. 2020;96(4):32–42. [Drozhdina MB, Kolevatykh EP, Trubnikova MA, Kryazheva PA. Age correlations of acne vulgaris. Comparative study of microbiome and acne exposom at students of Kirov state medical university. Analysis of the results of therapy applicable to indicators of quality of life. Vestnik Dermatologii i Venerologii. 2020;96(4):32–42. (In Russ.)]. doi: 10.25208/vdv1143-2020-96-4-32-42</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Дрождина М.Б., Бобро В.А. Подрывающий фолликулит Гоффмана—состояние проблемы, подходы к терапии, демонстрация клинических случаев. Вестник дерматологии и венерологии. 2020;97(2):35–43. [Drozhdina MB, Bobro VA. Hoffman's Recalcitrant Dissecting Folliculitis — State of the Problem, Approach to Therapy, Demonstration of Clinical Cases. Vestnik Dermatologii i Venerologii. 2020;97(2):35–43 (In Russ.)]. doi: 10.25208/vdv1139</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Дрождина М.Б. Применение Акнекутана для лечения фульминантных акне. Консилиум. Дерматовенерология. 2019;2(171):25. [Drozdina M.B. The usage of Aknekutan for the treatment of fulminant acne. Consultation. Dermatovenereology. 2019;2(171):25 (In Russ.)]</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Сергеева И.Г., Криницына Ю.М., Онипченко В.В., Гвоздарева М.А., Дягилева А.А. Клинико-морфологическая характеристика состояния кожи пациентов с акне в динамике терапии изотретиноином в форме LIDOSE. Вестник дерматологии и венерологии. 2012;2:120–126. [Sergeeva IG, Krinitsyna YuM, Onipchenko VV, Gvozdareva MA, Diagileva AA. Clinical and morphological characteristics of the skin condition of acne patients in the dynamics of isotretinoin therapy in the form of LIDOSE. Bulletin of Dermatology and Venereology. 2012;2:120–126 (In Russ.)]</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Chandra M, Levitt J, Pensabene CA. Hydroquinone therapy for post-inflammatory hyperpigmentation secondary to acne: not just prescribable by dermatologists. Acta Derm Venereol. 2012;92:232–235.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Самцов А.В., Аравийская Е.Р. Акне и розацеа. М: ООО «Фармтек», 2021. 400 с.: илл. [Samtsov AV, Araviiskaya ER. Acne and rosacea. Moscow: “Farmtec”, 2021. 400 p., ill. (In Russ.)]</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Goodman GJ, Baron JA. Postacne scarring—a quantitative global scarring grading system. Journal of Cosmetic Dermatology. 2006;5(1):48–52. doi: 10.1111/j.1473-2165.2006.00222.x</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Tan J, Kang S, Leyden J. Prevalence and risk factors of acne scarring among patients consulting dermatologists in the United States. J. Drugs Dermatol. 2017;16:97–102.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Guerrero D. Dermocosmetic management of hyperpigmentations. Ann Dermatol Venereol. 2012;139(4):166–169.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Круглова Л.С., Грязева Н.В., Талыбова А.М. Симптомокомплекс постакне: методы профилактики и терапии. Клиническая дерматология и венерология. 2020;19(5):622–629. [Kruglova LS, Griazeva NV, Talibova AM. Post-acne symptom complex: methods of prevention and therapy. Klinicheskaya Dermatologiya I Venerologiya. 2020;19(5):622–629 (In Russ.)]. doi 10.17166/klinderma202019051622</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Chandrashekar BS, Varsha DV, Vasanth V, Jagadish P, Madura C, Rajashekar ML. Safety of performing invasive acne scar treatment and laser hair removal in patients on oral isotretinoin: a retrospective study of 110 patients. Int J Dermatol. 2014;53(10):1281–1285. doi: 10.1111/ijd.12544</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Yoon JH, Park EJ, Kwon IH, Kim CW, Lee GS, Hann SK, et al. Concomitant use of an infrared fractional laser with low-dose isotretinoin for the treatment of acne and acne scars. J Dermatolog Treat. 2014;25(2):142–146. doi: 10.3109/09546634.2013.768758</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Galani JHY, Patel JS, Patel NJ, Talati JG. Storage of Fruits and Vegetables in Refrigerator Increases their Phenolic Acids but Decreases the Total Phenolics, Anthocyanins and Vitamin C with Subsequent Loss of their Antioxidant Capacity. Antioxidants (Basel). 2017;24;6(3):59. doi: 10.3390/antiox6030059</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Суркичин С.И., Грязева Н.В., Круглова Л.С.. Эффективность геля, содержащего комбинацию активных веществ, в лечении поствоспалительной гиперпигментации. Клиническая дерматология и венерология 2021;20(4):68–74. [Surkichin SI, Griazeva NV, Kruglova LS. The effectiveness of a gel containing a combination of active substances in the treatment of post-inflammatory hyperpigmentation. Russian Journal of Clinical Dermatology and Venereology Klinicheskaya dermatologiya i venerologiya 2021;20(4):68–74 (In Russ.)]. doi: 10.17116/klinderma20212004168</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Вашкевич А.А., Резцова П.А. Коррекция дисхромии и рубцов при постакне. Клиническая дерматологияивенерология 2021;20(6):98–103. [Vashkevich AA, Reztcova PA. The effectiveness of a gel containing a combination of active substances in the treatment of post-inflammatory hyperpigmentation. Russian Journal of Clinical Dermatology and Venereology Klinicheskaya dermatologiya I venerologiya 2021;20(6):98–103 (In Russ.)]. doi: 10.17116/klinderma20212006198</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Study Satisfaction test, Dermscan Asia, 2010 https://www.hiruscar.com/en/postacne</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>GhersetichI, Brazzini B, Lotti T. Chemical peeling. In: Lotti TM, Katsambas AD, editors. European Handbook of Dermatological Treatments. 2nd edition. Berlin, Germany: Springer; 2003.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Fabbrocini G, Fardella N, Monfrecola A, Proietti I, Innocenzi D. Acne scarring treatment using skin needling. Clinical and Experimental Dermatology. 2009;34(8):874–879. doi: 10.1111/j.1365-2230.2009.03291.x</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Landau M. Chemical peels. Clinics in Dermatology. 2008;26(2):200–208. doi: 10.1016/j.clindermatol.2007.09.012</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Goodman GJ. Postacne scarring: a review of its pathophysiology and treatment. Dermatologic Surgery. 2000;26(9):857–871. doi: 10.1046/j.1524-4725.2000.99232.x</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Agarwal N, Gupta LK, Khare AK, Kudeep CM, Mittal A. Therapeutic response of 70% trichloroacetic acid CROSS in atrophic acne scars. Dermatol Surg. 2015;41(5):597–604. doi: 10.1097/DSS.0000000000000355</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Covarrubias P, Cardenas Camarena L, Guerrerosantos J, Valenzuela L, Espejo I, Robles JA, Gioia S. Evaluation of the histologic changes in the fat-grafted facial skin: clinical trial. Aesthet Plast Surg 2013; 37:778–783. doi: 10.4103/mmj.mmj_718_16</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Cooper JS, Lee BT. Treatment of facial scarring: lasers, filler, and nonoperative techniques.Facial Plast Surg.2009;25(5):311–315. doi: 10.1055/s-0029-1243079</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Rivera AE. Acne scarring: a review and current treatment modalities. J Am Acad Dermatol. 2008;59(4):659–676.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Круглова Л.С., Колчева П.А., Коржачкина Н.Б. Обзор современных методов коррекции рубцов и постакне. Вестник новых медицинских технологий. 2018;25(4):155–163. [Kruglova LS, Kolcheva PA, Korzhachkina NB. About modern methods of acne scars correction.Journal of new medical technologies. 2018;25(4):155–163 (In Russ.)]</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Agarwal N, Mittal A, Kuldeep C. Chemical reconstruction of skin scars therapy using 100% trichloroacetic acid in the treatment of atrophic facial post varicella scars: a pilot study. J Cutan Aesthet Surg. 2013;6(3):144–147. Doi: 10.4103/0974-2077.118408</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Halachmi S, Ben Amitai D, Lapidoth M. Treatment of acne scars with hyaluronic acid: an improved approach. J Drugs Dermatol. 2013;12(7):e121–e123.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>W. Philip Werschler, Richard S. Herdener, Victor E. Rossand Edward Zimmerman. Treating Acne Scars: What's New? Consensus from the Experts. J Clin Aesthet Dermatol. 2015;8(8 Suppl):2–8.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Потекаев Н.Н., Круглова Л.С. Лазер в дерматологии и косметологии. М. 2012. Вып. МДВ;280. [Potekaev NN, Kruglova LS. Laser in dermatology and cosmetology. M. 2012. Issue. MDV; 280. (In Russ.)]</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Талыбова А.М., Круглова Л.С., Стенько А.Г. Лазерная терапия в коррекции атрофических рубцов. Физиотерапевт. 2017;1:64–70. [Talibovа AM, Kruglova LS, Stenko AG. The additive (laser) therapy of atrophic scars. Journal “Physiotherapist” 2017;1:64–70. (In Russ.)]</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Tierney EP et al. Fractionated CO2 laser skin rejuvenation. Dermatol Ther. 2011;24 (1):41–53.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Georgios Kravvas1 and Firas Al-Niaimi. A systematic review of treatments for acne scarring. Part 2: Energybased techniques.Scars, Burns &amp; Healing Volume 4: 1–14 doi: 10.1177/2059513118793420</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Yur-Ren Kuo, Seng-Feng Jeng, Feng-Sheng Wang, Hui-Chen Huang BS, Cha-Zon Lin BS, Kuender D. Yang. Suppressed TGF-β1 expression is correlated with up-regulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment. Lasers in Surgery and Medicine. 2005;36(1):38–42. doi: 10.1002/lsm.20104</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Patel N, Clement M. Selective nonablative treatment of acne scarring with 585 nm flashlamp pulsed dye laser. Dermatol Surg. 2002;28:942–945; discussion 945.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Mathew ML, Karthik R, Mallikarjun M, Bhute S, Varghese A. Intense pulsed light therapy for acne-induced post-inflammatory erythema. IndianDermatolOnlineJ. 2018;9:159–164.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Дрождина М.Б., Бобро В.А. Ринофима как наиболее тяжелый подтип розацеа. Диагностика и терапевтическая тактика. Демонстрация клинического случая. Вестник дерматологии и венерологии. 2022;98(1):35–43. [Drozhdina MB, Bobro VA. Rhinophyma as the most severe subtype of rosacea. Diagnostics and therapeutic tactics. Demonstration of a clinical case.Vestnik Dermatologii i Venerologii. 2022;98(1):35–43 (In Russ.)]</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Atula Gupta, Maninder Kaur, Suman Patra, NitiKhunger, and Somesh Gupta. Evidence-based Surgical Management of Post-acne Scarring in Skin of Color. J Cutan Aesthet Surg. 2020;13(2):124–141. doi: 10.4103/JCAS.JCAS_154_19</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Дрождина М.Б. Болезнь Морбигана. Современный обзор литературы. Описание редкого клинического случая. Медицинский вестник Северного Кавказа. 2020;15(1):15–21. [Drozhdina MB. Morbihan disease. A modern review of the literature. Description of a rare clinical case. Medical news of North Caucasus. 2020;15(1):129–133 (In Russ.)]. doi: 10.14300/mnnc.2020.15033</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Murad Alam, Nayomi Omura, Michael S Kaminer. Subcision for Acne Scarring: Technique and Outcomes in 40 Patients. April 2005. Dermatologic Surgery 31(3):310–317; discussion 317. doi: 10.1111/j.1524-4725.2005.31080</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Kang WH, Kim YJ, Pyo WS, Park SJ, Kim JH. Atrophic acne scar treatment using triple combination therapy: dot peeling, subcision and fractional laser. Journal of Cosmetic and Laser Therapy. 2009;11(4):212–215. doi: 10.3109/14764170903134326</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Peter G Shakespere. International clinical recommendations on scar management. Plastic and Reconstructive Surgery. 2002;110(2):560–571. doi: 10.1097/00006534-200208000-00031</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Goodman GJ. Treating scars: Addressing surface, volume, and movement to optimize results: Part 1. Mild grades of scarring. Dermatol Surg. 2012;38:1302–1309.</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Goodman GJ. Treating scars: Addressing surface, volume, and movement to expedite optimal results. Part 2: More-severe grades of scarring. Dermatol Surg. 2012;38:1310–1321.</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Benjamin Bleasdale, Simon Finnegan, Kathyryn Murray, Sean Kelly, and Steven L. Percival. The Use of Silicone Adhesives for Scar Reduction. Adv Wound Care (New Rochelle). 2015;4(7):422–430. doi: 10.1089/wound.2015.0625</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Rabello FB, Souza CD, Farina Júnior JA. Update on hypertrophic scar treatment. Clinics 2014;69:565–573.</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Puri N, Talwar A. The efficacy of silicone gel for the treatment of hypertrophic scars and keloids. J Cutan Aesthet Surg 2009;2:104–106.</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Shashank Bhargava, R. D. Gardi, Paulo Rowilson Cunha, Jennifer Lee, George Kroumpouzos. Acne Scarring Management: Systematic Review and Evaluation of the Evidence. April 2018. American Journal of Clinical Dermatology 19(9). doi: 10.1007/s40257-018-0358-5</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Cavalie M, Sillard L, Montaudie H, Bahadoran P, Lacour JP, Passeron T. Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases. Dermatol Ther. 2015;28(2):74–78. doi: 10.1111/dth.12187</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Kelly AP. Medical and surgical therapies for keloids. Dermatologic Therapy. 2004;17(2):212–218. doi: 10.1111/j.1396-0296.2004.04022.x</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Сергеева И.Г., Криницына Ю.М. Особенности липидного обмена при системной терапии ретиноидами. Вестник Новосибирского государственного университета. Серия: Биология, клиническая медицина. 2011; 9(1): 172–176. [Sergeeva IG, Krinitsyna Yu M Features of the lipide exchange at system the rapy of retinoids. Vestnik of Novosibirsky state university. 2011;9(1):172–176 (In Russ.)]</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Gerd G Gauglitz. Management of keloids and hypertrophic scars: current and emerging options. Clin Cosmet Investig Dermatol. 2013;6:103–114. doi: 10.2147/CCID.S35252</mixed-citation></ref></ref-list></back></article>
